Poolbeg Pharma upbeat on preliminary influenza drug results
News release
by
Poolbeg Pharma PLC
London, UK
|
January 09, 2023 09:01 AM Eastern Standard Time
Poolbeg Pharma PLC (OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing initial data analysis, including a 'clear dose-related response', for its drug, POLB 001, a potential treatment for severe influenza. Skillington says the 'early data readout' indicates that the challenge trial was successful.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
